Ebola Virus Disease (EVD) is a severe, often fatal illness affecting humans and other primates. Caused by the Ebolavirus genus within the Filoviridae family, the virus leads to a devastating multisystem syndrome. The natural reservoir hosts are fruit bats of the Pteropodidae family. Once introduced into the human population, the virus spreads rapidly through direct contact with infected bodily fluids. Understanding the virology helps Nigerian nurses recognize the high risk of nosocomial transmission during outbreaks, particularly in under-resourced primary health centres where standard precautions may occasionally lapse.
The Ebola virus targets endothelial cells, mononuclear phagocytes, and hepatocytes. Upon entering the body, it disrupts the immune system by inhibiting interferon responses, leading to massive inflammatory cytokine release. This causes vascular instability, impaired blood coagulation, and multi-organ failure.
Transmission occurs strictly through:
Ebola presents with a non-specific prodrome that mimics malaria or typhoid fever, complicating early diagnosis in Nigerian primary care. Symptoms evolve through distinct phases over one to three weeks.
Clinical assessment requires rigorous adherence to infection control before touching the patient. Nurses must obtain a thorough epidemiological history alongside physical signs. Key travel history and contact with suspected cases within the past 21 days guide suspicion. Definitive diagnosis relies on laboratory confirmation using Reverse Transcription-Polymerase Chain Reaction (RT-PCR) assay. Blood draw must be executed with extreme caution to prevent needle-stick injuries and accidental exposure.
There is no guaranteed single cure for EVD, making aggressive supportive care the cornerstone of survival. Management focuses on maintaining hemodynamic stability, correcting electrolyte imbalances, and treating concurrent infections.
| Clinical Goal | Nursing Intervention | Rationale |
|---|---|---|
| Rehydration | Administer oral rehydration salts or IV fluids | Replaces massive fluid losses from vomiting and diarrhea |
| Electrolyte Balance | Monitor serum levels and infuse correct crystalloids | Prevents fatal cardiac arrhythmias and muscle spasms |
| Symptom Relief | Administer antipyretics and antiemetics | Controls high fever and reduces severe nausea |
| Nutritional Support | Provide early enteral nutrition when tolerated | Preserves gut mucosal integrity and immune function |
Standard precautions are insufficient when managing suspected viral hemorrhagic fevers. Healthcare facilities must enforce rigorous transmission-based precautions.
Public health containment relies heavily on active community engagement and systematic contact tracing. Nurses working in primary care often lead community sensitization efforts to dispel myths and reduce stigma. Contact tracing involves identifying everyone who interacted with an infected person during their symptomatic window and monitoring them daily for fever or other signs for 21 days. Quick identification of secondary cases prevents widespread community transmission.
Surviving acute EVD brings new clinical challenges known as Post-Ebola Syndrome (PES) or post-Ebola sequelae. Survivors frequently report chronic arthralgia, myalgia, severe fatigue, headaches, and ocular complications such as uveitis that can lead to blindness. Furthermore, the virus can persist in immunologically privileged sites like the testes, eyes, and central nervous system for months, posing a risk of sexual transmission. Comprehensive nursing follow-up and psychosocial support are vital for reintegrating survivors into their communities.